Calcium Supplement Market in Korea – Consumer Trends & Demand

An In-depth Industry Analysis of Calcium Supplement in Korea from 2023 to 2033

The industry size of calcium supplement in Korea is estimated to be USD 96 million in 2023. The industry is estimated to surpass USD 279.4 million by 2033, exhibiting 11.3% CAGR.

The industry analysis suggests that demand for personal care products and dietary supplements drives the trend of health related supplementation like calcium supplement.

Size, Analysis and Insights of Calcium Supplement Industry in Korea

• Increased health consciousness and the use of dietary supplements in the country are contributing to the rapid and profitable expansion of the industry. The pharmaceutical manufacturing industry's widespread presence across the country is expected to further contribute to industry growth.
• People are becoming more aware of the adverse effects of calcium deficiency in the body. Consequently, they are beginning to consume calcium supplements as part of a balanced diet system prepared by nutritionists, leading to an increased demand for calcium supplements.

Attributes	Details
Korea Calcium Supplement Industry Value for 2023	USD 96 million
Projected Industry Value for 2033	USD 279.4 million
Value-based CAGR for 2023 to 2033	11.3%

Trends in the Calcium Supplement Industry in Korea

• Calcium supplements, in particular, are gaining popularity as an easy choice for maintaining good bone health. They are expected to become more prevalent in the next few years as people become more aware of the science behind the body's need for calcium and its potential benefits in the healthy functioning of the heart, muscles, and neurons.
• People are increasingly turning to plant-based supplement products rather than animal-based proteins as the popularity of cruelty-free products grows. Furthermore, plant-based vitamins and minerals are considerably healthier and better digested in the body than synthetic ones.
• Many individuals are turning to herbal health supplements and herbs. Additionally, companies are increasingly attracted to offering eco-friendly and clean-label products to match growing customer tastes and reduce their harmful ecological impact.
• The shift toward eCommerce has created opportunities for health supplement brands to reach a wider audience and expand their online presence. In addition, there has been a heightened focus on self-care and wellness. Many people have turned to supplementation as a form of self-care and a way to maintain a sense of normalcy during uncertain times.
• Manufacturers are increasingly focusing on new developments that provide precise offerings while recycling waste materials in the country.

Challenges for the Calcium Supplement Industry in Korea

• Growing public understanding of the harmful effects of excess intake of dietary supplements is expected to hinder calcium supplement sales.
• Increasing consumer demand for consistency in product ingredients presents an essential challenge to industry expansion.

Category-wise Outlook

The report on the calcium supplement industry in Korea can be divided into two segments: form and end use, with a notable dominance observed in the soft gel form and men end use categories.

Soft Gel Segment Dominates the Industry by Form

The soft gel segment is expected to hold an industry share of 56.1% in 2023. It dominates the industry owing to its advantages, such as being easier to swallow and being ideal for oil- and fat-soluble formulations. The addition of carrageenan in vegetarian and vegan encapsulation enables people with dietary constraints to have more options in their supplement, vitamin, and mineral selections.

Attributes	Details
Form	Soft Gel
Industry Share in 2023	56.1%

Men Segment Dominates the Industry by End Use

The men's segment is expected to account for an industry share of 36.4% in 2023 due to the increasing use of supplements by men. The rising health consciousness and gymnasium lifestyle among men are expected to create significant opportunities for calcium supplement sales in Korea.

Attributes	Details
End Use	Men
Industry Share in 2023	36.4%

Competitive Landscape in the Calcium Supplement in Korea

Companies like Dong-A Pharmaceutical Co., Ltd., Youngpoong Pharma Corporation, Kyungdong Pharmaceutical Co., Ltd., and Green Cross Pharma Corporation already have a strong foothold in the industry. Manufacturers are creating strong brand identities through effective marketing strategies to boost customer retention. Manufacturing processes are being improved, and the supply chain is being optimized to enhance capacity and meet increased demand.

Key Companies

Dong-A Pharmaceutical Co., Ltd

Founded in 1945, Dong-A Pharmaceutical Co., Ltd. is one of the leading pharmaceutical companies in South Korea. The company produces a wide range of pharmaceutical products, including calcium supplements. Dong-A Pharmaceutical's calcium supplements are made with high-quality ingredients and have been clinically proven to be effective in increasing bone density and reducing the risk of osteoporosis.

Youngpoong Pharma Corporation

Youngpoong Pharma Corporation is a pharmaceutical company in South Korea. The company was founded in 1973 and produces a wide range of pharmaceutical products, including calcium supplements. Youngpoong Pharma's calcium supplements are made with high-quality ingredients and are clinically proven to be effective in increasing bone density and reducing the risk of osteoporosis.

Key Players Offering Calcium Supplement in Korea

• Dong-A Pharmaceutical Co., Ltd.
• Youngpoong Pharma Corporation
• Kyungdong Pharmaceutical Co., Ltd.
• Green Cross Pharma Corporation
• Samyang Holdings Co., Ltd.
• First Pharmaceutical Co., Ltd.
• JW Pharmaceutical Co., Ltd.
• Chunyang Pharmaceutical Co., Ltd.
• Hansong Pharmaceutical Co., Ltd.
• Ottogi Corporation
• GSK
• Pfizer
• Bayer
• Novartis
• Abbott
• Eisai
• Takeda
• Astellas
• AstraZeneca
• Sanofi

Scope of the report

Attribute	Details
Estimated Industry Size in 2023	USD 96 million
Projected Industry Size by 2033	USD 279.4 million
Anticipated CAGR between 2023 to 2033	11.3% CAGR
Historical Analysis of Demand for Calcium supplement in Korea	2018 to 2022
Demand Forecast for Calcium supplement in Korea	2023 to 2033
Report Coverage	Industry Size, Industry Trends, Key Insights for Calcium supplement adoption in Korea, Insights on Global Players and Leading Industry Strategy in Korea, Ecosystem Analysis of Local and Regional.
Key Companies Profiled	Dong-A Pharmaceutical Co., Ltd.; Youngpoong Pharma Corporation; Kyungdong Pharmaceutical Co., Ltd.; Green Cross Pharma Corporation; Samyang Holdings Co., Ltd.; First Pharmaceutical Co., Ltd.; JW Pharmaceutical Co., Ltd.; Chunyang Pharmaceutical Co., Ltd.; Hansong Pharmaceutical Co., Ltd.; Ottogi Corporation; GSK; Pfizer; Bayer; Novartis; Abbott; Eisai; Takeda; Astellas; AstraZeneca; Sanofi

Table of Content

• 1. Executive Summary
• 2. Market Overview
• 3. Market Background
• 4. Industry Analysis and Outlook 2018 to 2022 and Forecast, 2023 to 2033
• 5. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Type
  • 5.1. Gummy
  • 5.2. Pill
  • 5.3. Capsule
  • 5.4. Liquid
  • 5.5. Others
• 6. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Product
  • 6.1. Calcium Carbonate
  • 6.2. Calcium Gluconate
  • 6.3. Calcium Citrate
  • 6.4. Calcium Lactate
  • 6.5. Calcium Phosphate
  • 6.6. Calcium Orotate
• 7. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Applications
  • 7.1. Adult
  • 7.2. Children
• 8. Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033, By Region
  • 8.1. South Gyeongsang
  • 8.2. North Jeolla
  • 8.3. South Jeolla
  • 8.4. Jeju
  • 8.5. Rest of
• 9. South Gyeongsang Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
• 10. North Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
• 11. South Jeolla Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
• 12. Jeju Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
• 13. Rest of Industry Analysis and Outlook 2018 to 2022 and Forecast 2023 to 2033
• 14. Market Structure Analysis
• 15. Competition Analysis
  • 15.1. Omya
  • 15.2. Pipelinepharma
  • 15.3. Pfizer (Caltrate)
  • 15.4. AandZ Pharmaceutical
  • 15.5. Amway (Nutrilite)
  • 15.6. Shanxi Zhendong Pharmaceutical Co., Ltd.
  • 15.7. Nature Made
  • 15.8. By-health Co., Ltd.
  • 15.9. Harbin Pharmaceutical Group
  • 15.10. Bayer AG
• 16. Assumptions & Acronyms Used
• 17. Research Methodology